Enzymology of the reductive bioactivation of SR 4233
Authors:
- Paul WorkmanPWPaul Workman
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (11) , 1735-1742
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Enzyme-Directed Bioreductive Drug Development1990
- Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Structure-activity relationships for benzotriazine DI-N-oxidesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- High-performance liquid chromatographic assay for the benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materialsJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxideBiochemical Pharmacology, 1986
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- Reductive Drug MetabolismDrug Metabolism Reviews, 1983
- [56] DT diaphorase1967